Cancer Family
Neck Neoplasm
CI-CAN-00000283Explore in graph →
Non-malignant634 active trials11 approved drugs67 evidence items
- NCIt
- C3260
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000283Explore in graph →
Clinical trials
2,377 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01757470 | Vandetanib Risk Minimisation Effectiveness | completed | — | 12 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Aug 31, 2016 | clinicaltrials |
| NCT02505139 | The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC Patients | completed | — | 166 | Sun Yat-sen UniversityOTHER | 0 | Aug 29, 2016 | clinicaltrials |
| NCT02881723 |
| Obstructive Sleep Apnea Syndrome After Oropharyngeal Cancer Treatment |
| unknown |
| N/A |
| 51 |
| Assistance Publique Hopitaux De MarseilleOTHER |
| 1 |
| Aug 29, 2016 |
| clinicaltrials |
| NCT02515084 | Comparison DW-MRI vs FDG PET/CT in the Detection of Early Recurrence of Cervical Well-differentiated Thyroid Carcinoma(THYRIRMTEP) | completed | Phase 2 | 37 | Centre Henri BecquerelOTHER | 1 | Aug 24, 2016 | clinicaltrials |
| NCT02869620 | Institut Paoli Calmettes Thyroid Cancer Database | recruiting | — | 3,000 | Institut Paoli-CalmettesOTHER | 1 | Aug 17, 2016 | clinicaltrials |
| NCT02854410 | Dietary Nitrate on Salivary Flow for Nasopharyngeal Carcinoma Patients | unknown | N/A | 30 | Capital Medical UniversityOTHER | 1 | Aug 3, 2016 | clinicaltrials |
| NCT01528137 | Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer | terminated | Phase 1 | 4 | Stanford UniversityOTHER | 1 | Aug 2, 2016 | clinicaltrials |
| NCT02334319 | Ganetespib Window of Opportunity Study in Head and Neck Cancers | terminated | Phase 1 | 3 | Emory UniversityOTHER | 1 | Jul 26, 2016 | clinicaltrials |
| NCT02523430 | HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Nasopharyngeal Carcinoma | completed | Phase 1 / Phase 2 | 60 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jul 19, 2016 | clinicaltrials |
| NCT01204476 | Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 1 | Jul 15, 2016 | clinicaltrials |
| NCT01403324 | Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer(DOSIMETA) | terminated | N/A | 4 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT01155258 | Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 19 | University of Southern CaliforniaOTHER | 1 | Jun 13, 2016 | clinicaltrials |
| NCT02080416 | Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors | terminated | Early Phase 1 | 1 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jun 10, 2016 | clinicaltrials |
| NCT02786641 | Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 3 | 235 | Sun Yat-sen UniversityOTHER | 1 | Jun 1, 2016 | clinicaltrials |
| NCT02610556 | Concurrent Docetaxel Plus Cisplatin or Cisplatin Alone With IMRT in High Risk Nasopharyngeal Carcinoma | unknown | Phase 2 | 130 | Sun Yat-sen UniversityOTHER | 1 | May 26, 2016 | clinicaltrials |
| NCT02558803 | HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3 | completed | N/A | 1,305 | Regenstrief Institute, Inc.OTHER | 1 | May 25, 2016 | clinicaltrials |
| NCT01108042 | TPF-Induction Chemotherapy of Oropharyngeal and Cavity of the Mouth Cancer | completed | Phase 1 / Phase 2 | 71 | Orlando Guntinas-Lichius, Prof. Dr. med.OTHER | 1 | May 18, 2016 | clinicaltrials |
| NCT02761291 | Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma | unknown | Phase 1 | 18 | Chang Gung Memorial HospitalOTHER | 1 | May 16, 2016 | clinicaltrials |
| NCT00537199 | OraTest in Combination With Visual Examination and Visual Examination Alone | terminated | Phase 3 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | May 13, 2016 | clinicaltrials |
| NCT01625520 | SOM230 Alone or in Combination With RAD001 in Patients With Medullary Thyroid Cancer | completed | Phase 2 | 19 | Federico II UniversityOTHER | 1 | Apr 25, 2016 | clinicaltrials |
| NCT01137097 | Lateral Neck Sentinel Lymph Node Biopsy(LSLNB)in PTC(LSLNB) | completed | Phase 2 / Phase 3 | 278 | Samsung Medical CenterOTHER | 1 | Apr 21, 2016 | clinicaltrials |
| NCT02119728 | Photodynamic Therapy With HPPH in Treating Patients With Squamous Cell Carcinoma of the Oral Cavity | withdrawn | Phase 2 | 0 | Roswell Park Cancer InstituteOTHER | 1 | Apr 21, 2016 | clinicaltrials |
| NCT02360501 | Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma | completed | Phase 2 | 50 | Sun Yat-sen UniversityOTHER | 1 | Apr 20, 2016 | clinicaltrials |
| NCT02505672 | Vestibular Function After Chemoradiotherapy for Nasopharyngeal Carcinoma | unknown | — | 50 | Rabin Medical CenterOTHER | 1 | Apr 19, 2016 | clinicaltrials |
| NCT00795782 | Prophylactic Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma | completed | Phase 3 | 258 | Samsung Medical CenterOTHER | 1 | Apr 15, 2016 | clinicaltrials |
| NCT02735317 | Efficacy and Safety of FORRAD® for the Management of Radiation-induced Mucositis in Patients With Nasopharyngeal Carcinoma Receiving IMRT | unknown | Phase 2 | 90 | Yun-fei XiaOTHER | 1 | Apr 12, 2016 | clinicaltrials |
| NCT02724176 | Potential Role for Carbon Nanoparticles to Guide Central Neck Dissection in Patients With Papillary Thyroid Cancer | completed | N/A | 140 | Peking University Cancer Hospital & InstituteOTHER | 0 | Mar 31, 2016 | clinicaltrials |
| NCT01792492 | The Role of an Optical Probe in Thyroid Cancer Diagnosis: Pilot Study | completed | — | 50 | Boston Medical CenterOTHER | 1 | Mar 29, 2016 | clinicaltrials |
| NCT02211222 | An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer | approved for marketing | — | — | Eisai Inc.INDUSTRY | 1 | Mar 16, 2016 | clinicaltrials |
| NCT02262247 | A Post-Market Clinical Trial for Access and Visualization of the Oropharynx, Hypopharynx and Larynx During Transoral Procedures | completed | — | 80 | Medrobotics CorporationOTHER | 2 | Mar 16, 2016 | clinicaltrials |
| NCT02551887 | HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts | completed | N/A | 647 | Regenstrief Institute, Inc.OTHER | 0 | Mar 11, 2016 | clinicaltrials |
| NCT00473564 | Robotic Assisted Surgery in Upper Aerodigestive Tract Surgery | completed | N/A | 170 | University of Alabama at BirminghamOTHER | 1 | Mar 8, 2016 | clinicaltrials |
| NCT02608073 | A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer | completed | Phase 2 | 45 | Hoffmann-La RocheINDUSTRY | 5 | Mar 2, 2016 | clinicaltrials |
| NCT00123760 | Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer | completed | Phase 2 / Phase 3 | 10,838 | AHS Cancer Control AlbertaOTHER | 1 | Feb 25, 2016 | clinicaltrials |
| NCT01695122 | Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma | completed | Phase 2 | 14 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Feb 23, 2016 | clinicaltrials |
| NCT01994200 | Developing and Implementing an Interdisciplinary Team-Based Care Approach (ITCA-ThyCa) for Thyroid Cancer Patients(ITCA-ThyCa) | withdrawn | Phase 1 / Phase 2 | 0 | Jewish General HospitalOTHER | 1 | Feb 23, 2016 | clinicaltrials |
| NCT02481089 | Polymorphisms in Key Genes of Glycolytic Pathway: Influence on Radiosensitivity in Nasopharyngeal Carcinoma | unknown | — | 600 | Hunan Province Tumor HospitalOTHER | 1 | Feb 19, 2016 | clinicaltrials |
| NCT02303457 | CO2 Laser and Open Surgery for T1N0 Glottic SCC With Anterior Commissure Involved | unknown | N/A | 402 | Xuekui LiuOTHER | 1 | Jan 28, 2016 | clinicaltrials |
| NCT02516774 | A Trial of Adalimumab Combined to Chemotherapy and Radiotherapy in Patients With Anaplastic Thyroid Cancers(TAM-RT) | withdrawn | Phase 1 | 0 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jan 26, 2016 | clinicaltrials |
| NCT02648399 | Prospective Study on the Clinical Prognosis of Bilateral Central Lymph Node Dissection in the Patients With Unilateral Thyroid Papillary Carcinoma | unknown | N/A | 300 | Fujian Medical UniversityOTHER | 1 | Jan 7, 2016 | clinicaltrials |
| NCT02645786 | Thyrotropin Over-suppression and Heart | completed | — | 31 | Chuncheon Sacred Heart HospitalOTHER | 0 | Jan 5, 2016 | clinicaltrials |
| NCT02250599 | Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 80 | Sun Yat-sen UniversityOTHER | 1 | Dec 30, 2015 | clinicaltrials |
| NCT00581815 | Spectroscopy With Surface Coils and Decoupling | completed | Phase 1 | 582 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 28, 2015 | clinicaltrials |
| NCT00454142 | Pazopanib Hydrochloride in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer | completed | Phase 2 | 33 | National Cancer Institute (NCI)NIH | 1 | Dec 17, 2015 | clinicaltrials |
| NCT02633176 | Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma | unknown | Phase 3 | 120 | Sun Yat-sen UniversityOTHER | 1 | Dec 17, 2015 | clinicaltrials |
| NCT01089803 | Observational Study of Swallowing Function After Treatment of Advanced Laryngeal Cancer | completed | — | 279 | University of MinnesotaOTHER | 1 | Dec 4, 2015 | clinicaltrials |
| NCT02621970 | Effect of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy in High Risk Nasopharyngeal Carcinoma | unknown | Phase 3 | 534 | Sun Yat-sen UniversityOTHER | 1 | Dec 4, 2015 | clinicaltrials |
| NCT00599131 | Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE) | terminated | Phase 2 | 4 | University of Michigan Rogel Cancer CenterOTHER | 1 | Dec 3, 2015 | clinicaltrials |
| NCT02610010 | Intensity-modulated Radiotherapy With or Without Concurrent Chemotherapy for Stage II Nasopharyngeal Carcinoma | unknown | Phase 3 | 462 | Sun Yat-sen UniversityOTHER | 1 | Nov 20, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Aug 31, 2016source: clinicaltrials